The Valley Desk

NCT02443298 · Interventional trial

Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma

Overall registry status Completed

Phase 2

Conditions Asthma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov